Wells Fargo’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38K Hold
1,738
﹤0.01% 6417
2026
Q1
$1.16K Hold
1,738
﹤0.01% 6321
2025
Q4
$1.15K Sell
1,738
-200
-10% -$158 ﹤0.01% 6274
2025
Q3
$1.5K Hold
1,938
﹤0.01% 6222
2025
Q2
$2.75K Hold
1,938
﹤0.01% 6166
2025
Q1
$2.52K Hold
1,938
﹤0.01% 6127
2024
Q4
$2.77K Hold
1,938
﹤0.01% 6146
2024
Q3
$6.3K Sell
1,938
-806
-29% -$2.19K ﹤0.01% 5888
2024
Q2
$6.48K Buy
2,744
+2,489
+976% +$9.26K ﹤0.01% 5829
2024
Q1
$1K Buy
255
+201
+372% +$588 ﹤0.01% 6150
2023
Q4
$98 Buy
+54
New +$106 ﹤0.01% 6775

Other funds holding COCH

Wells Fargo's COCH Position: Q2 2026 in Review

Wells Fargo held its Envoy Medical (COCH) position steady in Q2 2026 at 1,738 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #6417.

Wells Fargo first reported a position in COCH in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.48K in Q2 2024. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Wells Fargo held 1,738 shares of Envoy Medical worth $1.38K as of Q2 2026.
  • Wells Fargo left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6417 holding.
  • Wells Fargo first reported a position in Envoy Medical in Q4 2023 and has held it in 11 quarters since.
  • Wells Fargo's Envoy Medical position peaked at $6.48K in Q2 2024.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.